Featured NewsNovo Nordisk reveals obesity drug with up to 22 percent weight lossiraqupdate.comJanuary 24, 2025January 24, 2025 by iraqupdate.comJanuary 24, 2025January 24, 2025076 Novo Nordisk’s amycretin shows up to 22% weight loss in trials, boosting its stock by 6.87% as the drug exhibits safety and potential as a...
